Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study (Q73720147)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 August 2003

Language	Label	Description	Also known as
English	Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study	scientific article published on 01 August 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

M J Borowitz

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D J Pullen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J J Shuster

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Viswanatha

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

K Montgomery

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

C L Willman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

B Camitta

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Children's Oncology Group study

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

17

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1566-1572

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12886244%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

https://scigraph.springernature.com/pub.10.1038/sj.leu.2403001

0 references

Detection of minimal residual disease in acute lymphoblastic leukemia: the St Jude experience

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute lymphoblastic leukemia (ALL): detection of minimal residual disease (MRD) at flow cytometry

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Flow cytometric follow-up of minimal residual disease in bone marrow gives prognostic information in children with acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunophenotypical detection of minimal residual disease in acute leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

A competitive PCR-based method using TCRD, TCRG and IGH rearrangements for rapid detection of patients with high levels of minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene rearrangements as markers of clonal variation and minimal residual disease in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular relapse can be detected in blood in a sensitive and timely fashion in B-lineage acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection and quantitation of neoplastic cells in acute lymphoblastic leukaemia, by use of the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic importance of measuring early clearance of leukemic cells by flow cytometry in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Post-induction residual leukemia in childhood acute lymphoblastic leukemia quantified by PCR correlates with in vitro prednisolone resistance.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report fr

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

TEL gene rearrangement in acute lymphoblastic leukemia: a new genetic marker with prognostic significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of TEL-AML1 Fusion Transcripts and Response to Induction Therapy in Standard Risk Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Two cases of very late relapsing ALL carrying the TEL:AML1 fusion gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of TEL/AML1 fusion transcript in childhood B-precursor acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Minimal residual disease levels in bone marrow and peripheral blood are comparable in children with T cell acute lymphoblastic leukemia (ALL), but not in precursor-B-ALL

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of peripheral blood instead of bone marrow to monitor residual disease in children with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2403001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73720147&oldid=1766848782"